Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder

NCT03120468 EARLY_PHASE1 UNKNOWN

This is a pilot study designed to evaluate the safety, tolerability of Topiramate (TPM) + N-Acetyl Cysteine (NAC) in combination versus Topiramate (TPM) + placebo for the treatment of alcohol use disorder (AUD).

Details

Lead sponsor	Nassima Ait-Daoud Tiouririne
Phase	EARLY_PHASE1
Status	UNKNOWN
Enrolment	16
Start date	2017-05-01
Completion	2021-01

Conditions

• Alcoholism

Interventions

• Topiramate and N-Acetyl Cysteine
• Topiramate and Placebo

Primary outcomes

• Cognitive side effects — up to13 weeks
  Collection of self-report cognitive side effects

Countries

United States